impact factor
logo
 

Case Reports

 

Environmental triggers of autoimmunity in anti-synthetase syndrome: the lungs under the spot light


, , ,

 

CER6309
2013 Vol.31, N°6
PI 0950, PF 0953
Case Reports

Free to view
(click on article PDF icon to read the article)

PMID: 24021193 [PubMed]

Received: 26/01/2013
Accepted : 24/04/2013
In Press: 09/09/2013
Published: 20/12/2013

Abstract

The prevalence of interstitial lung involvement in anti-synthetase syndrome (anti-SS) may be as high as 70% and is a major contributor to morbidity and mortality. Histidyl-tRNA synthetase (Jo-1) is the most common autoantigenic target among the aminoacyl-tRNA synthetases. We report two well documented anti-SS cases where it was observed significant exposure to a known inhaled offending antigen, development of a lymphocytic interstitial lung disease (ILD) and negative auto-antibodies, interpreted at first as hypersensitivity pneumonitis. Only after 14 and 30 months, respectively, the development of systemic symptoms compatible with anti-SS and anti-Jo-1 was observed. A growing body of evidence suggests that the lungs are the environment in which Jo-1 autoimmunity may be initiated and propagated. The description of the clinical and laboratorial evolution of these patients together with accumulated evidence of biological plausibility support the hypothesis that anti-SS can follow an episode of lung inflammation secondary to inhaled antigen exposure.

Rheumatology Article